Lessons Learned from Recent FCPA and Anti- Corruption Enforcement Actions
March 7, 2017 • 10:15 am
Co-Chairs’ Welcoming Remarks
March 7, 2017 • 8:15 am
Keynote Address: Trends in FDCA Enforcement and Best Practices for Keeping You and Your Company in the Clear
March 6, 2017 • 9:00 am
The Enforcers Speak: US Attorney’s Office Roundtable
March 7, 2017 • 8:30 am
Not So Safe: Exploring the Boundaries of the Discount Safe Harbor in Light of Recent Court Decisions
March 6, 2017 • 1:00 pm
Off Label Promotion Update: Legalities, Practicalities, and Current Realities
March 6, 2017 • 9:30 am
Evaluating Potential Fraud and Abuse Risks When Working with New Technologies, Including Diagnostics, Combination Products, and LDTs
March 7, 2017 • 11:15 am
Developments with the False Claims Act and Qui Tam Enforcement in Light of the Escobar Decision
March 6, 2017 • 3:30 pm
Regulatory and Legal Considerations When Using Social Media to Promote Drugs and Medical Devices
March 7, 2017 • 12:00 pm
Pricing Considerations for the Compliance Agenda in an Evolving Environment
March 6, 2017 • 4:30 pm
Compliance Risk Assessment Masterclass: Ensuring that You Have a First-Class Compliance Program by Benchmarking at the Most Interactive Level
March 7, 2017 • 2:00 pm
The Yates Memorandum a Year Later
March 6, 2017 • 2:15 pm
Patient Assistance Programs: How to Structure and Manage Them without Running Afoul of Evolving Regulatory Enforcement Theories
March 6, 2017 • 11:00 am
Sunshine Act Compliance Working Group: Deciphering the Latest Developments and How Open Payments Data Is Being Used in Government Investigations
March 8, 2017 • 9:00 am
Receive exclusive discounts, offers and agenda updates directly to your inbox.
